1. Home
  2. CPIX vs ORIS Comparison

CPIX vs ORIS Comparison

Compare CPIX & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

N/A

Current Price

$3.09

Market Cap

73.6M

Sector

Health Care

ML Signal

N/A

ORIS

Oriental Rise Holdings Limited Ordinary Shares

N/A

Current Price

$0.70

Market Cap

1.3M

ML Signal

N/A

Company Overview

Basic Information
Metric
CPIX
ORIS
Founded
1999
2014
Country
United States
China
Employees
N/A
69
Industry
Biotechnology: Pharmaceutical Preparations
Farming/Seeds/Milling
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
73.6M
1.3M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
CPIX
ORIS
Price
$3.09
$0.70
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
136.9K
91.8K
Earning Date
06-03-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
58.70
N/A
EPS
N/A
N/A
Revenue
$42,010,949.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$152.96
Revenue Growth
16.75
N/A
52 Week Low
$1.85
$0.06
52 Week High
$6.27
$1.87

Technical Indicators

Market Signals
Indicator
CPIX
ORIS
Relative Strength Index (RSI) 33.29 31.41
Support Level $2.78 $0.11
Resistance Level $3.85 $0.97
Average True Range (ATR) 0.32 0.13
MACD -0.13 -0.04
Stochastic Oscillator 3.48 23.84

Price Performance

Historical Comparison
CPIX
ORIS

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About ORIS Oriental Rise Holdings Limited Ordinary Shares

Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).

Share on Social Networks: